Neurology Main > Neuroimmunology & Multiple Sclerosis
ln

FAQ
Glossary
Research
- Clinical Trials
Treatment
- Cyclophosphamide (Cytoxan)
- First Line Disease Modifying Therapies
- Intravenous Immunoglobulin (IVIG)
- Methotrexate
- Mitoxantrone (Novantrone)
- Natalizumab (Tysabri)
- Rituximab (Rituxan)
- Solu-Medrol

Appointments and Referrals

Faculty
- Jaime Imitola, MD
- D. Joanne Lynn, MD
- Michael Racke, MD
Infusion Nurses
- Cynthia Hunter, RN
- Nancy, Ficco, RN
Research Staff
- Misty Regula
- Stephanie Scarberry, RN

Contact us at 614.293.4969

Currently Enrolling Clinical Trials in MS
ln

The Neuroimmunology and Multiple Sclerosis Division at The Ohio State University Medical Center is committed to improving the lives of MS patients through new treatments and innovative care. We continually initiate new clinical trials to help us meet this goal. Please visit this site often to determine if you or someone you know may be eligible to participate in one of our clinical trials. Without research and research volunteers there will be no advancements against this disease.